| Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence (NCT06558019) | Lei Li | 2024-10-01 |
| Cervical Cytology DNA Methylation for Cervical Cancer Screening (NCT06557954) | Lei Li | 2024-09-01 |
| A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening (NCT06491888) | Lei Li | 2024-08-01 |
| A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection (NCT06481930) | Lei Li | 2024-07-01 |
| ctDNA Methylation for Epithelial Ovarian Cancer (NCT05801263) | Lei Li | 2023-03-24 |
| ctDNA Methylation for Detecting Ovarian Cancer (NCT05801276) | Lei Li | 2023-03-24 |
| HRD Status Reference Standard Based on WGS (NCT06490380) | Lei Li | 2022-12-30 |
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer (NCT05311566) | Lei Li | 2022-03-27 |
| Niraparib Plus Anlotinib for Recurrent Ovarian Cancer (NCT05311579) | Lei Li | 2022-03-27 |
| Donafenib for Recurrent Cervical Cancer (NCT05310331) | Lei Li | 2022-03-27 |
| Tislelizumab and Radiotherapy for Recurrent Cervical Cancer (NCT05310383) | Lei Li | 2022-03-27 |
| HRD and Resistance to PAPPi in EOC Patients (NCT05310370) | Lei Li | 2022-03-26 |
| Prognosis of Low-grade Endometrial Stromal Sarcoma (NCT05310318) | Lei Li | 2022-03-26 |
| Chromosomal Instability in Ovarian Cancer (NCT05310357) | Lei Li | 2022-03-26 |
| PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer (NCT05310305) | Lei Li | 2022-03-26 |
| Cervical Cancer Screening Strategies (NCT05309122) | Lei Li | 2022-03-19 |
| Host DNA Methylation for Endometrial Cancer Screening (NCT05290415) | Lei Li | 2022-03-13 |
| Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial (NCT05290935) | Lei Li | 2022-03-13 |
| DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening (NCT05290922) | Lei Li | 2022-03-12 |
| Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma (NCT04664244) | Lei Li | 2020-12-19 |
| Cell-free DNA Methylation for Endometrial Cancer (NCT04651738) | Lei Li | 2020-12-18 |
| Immunohistochemical Staining of p16 for the Screening of Cervical Cancer (NCT04650711) | Lei Li | 2020-11-26 |
| A Training Set for the HRD Model in EOC (NCT04651933) | Lei Li | 2020-11-26 |
| A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer (NCT04651920) | Lei Li | 2020-11-26 |
| Cell-free DNA Methylation for Epithelial Ovarian Cancer (NCT04651946) | Lei Li | 2020-11-26 |
| Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas (NCT04635956) | Lei Li | 2020-11-15 |
| National Survey of Workplace Violence (NCT04492085) | Lei Li | 2020-07-27 |
| National Survey of the Impact of COVID-19 Pandemics (NCT04491201) | Lei Li | 2020-07-27 |
| Genetic Mutation in Epithelial Ovarian Cancer (NCT04191252) | Lei Li | 2019-12-19 |
| Genetic Mutation in Recurrent Cervical Cancer (NCT04191226) | Lei Li | 2019-12-19 |
| Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer (NCT04190667) | Lei Li | 2019-12-07 |
| Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy (NCT04188860) | Lei Li | 2019-12-06 |
| First-line Chemotherapy for Recurrent Cervical Cancer (NCT04188847) | Lei Li | 2019-12-06 |
| Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer (NCT04101760) | Lei Li | 2019-10-01 |
| Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis (NCT04010487) | Lei Li | 2019-07-16 |
| Comprehensive Study on the Quality of Life in Cervical Cancer Patients (NCT03967457) | Lei Li | 2019-06-19 |
| NAC Followed by RH for the Treatment of LACC (NCT03963882) | Lei Li | 2019-06-19 |
| A Cohort Study for the Following up of Conization (NCT03961178) | Lei Li | 2019-06-03 |
| DNA Methylation for Screening Uterine Cervical Lesions (NCT03960879) | Lei Li | 2019-06-01 |
| DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study (NCT03961191) | Lei Li | 2019-05-22 |
| G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients (NCT03793205) | Lei Li | 2019-01-03 |
| Different Surgical Approaches in Patients of Early-stage Cervical Cancer (NCT03739944) | Lei Li | 2018-11-23 |
| Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline (NCT03740672) | Lei Li | 2018-11-22 |
| HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma (NCT03742869) | Lei Li | 2018-11-10 |
| Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer (NCT03738969) | Lei Li | 2018-11-10 |
| A Multi-omics Study of Adenomyosis (NCT03742843) | Lei Li | 2018-11-10 |
| Functional Training for the Prevention of Deep Venous Thrombosis (NCT03740633) | Lei Li | 2018-11-10 |
| MSI in Circulatory DNA of Endometrial Cancer (NCT03744962) | Lei Li | 2018-11-10 |
| Long-acting G-CSF for Febrile Neutropenia (NCT03740464) | Lei Li | 2018-11-10 |
| A Multi-omics Study of Epithelial Ovarian Cancer (NCT03742856) | Lei Li | 2018-11-10 |
| Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer (NCT03738319) | Lei Li | 2018-11-10 |
| Pelvic Microbiomes of Benign and Malignant Ovarian Diseases (NCT03388996) | Lei Li | 2018-01-01 |
| Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer (NCT03291106) | Lei Li | 2017-09-01 |
| Survival Outcomes of Uterine Malignancies in Chinese Population (NCT03291275) | Lei Li | 2017-09-01 |